OA09908A - Treatment of neoplastic disease with interleukin-10 - Google Patents

Treatment of neoplastic disease with interleukin-10

Info

Publication number
OA09908A
OA09908A OA60389A OA60389A OA09908A OA 09908 A OA09908 A OA 09908A OA 60389 A OA60389 A OA 60389A OA 60389 A OA60389 A OA 60389A OA 09908 A OA09908 A OA 09908A
Authority
OA
OAPI
Prior art keywords
interleukin
treatment
neoplastic disease
patient
effective amount
Prior art date
Application number
OA60389A
Other languages
English (en)
Inventor
Paulo J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA09908A publication Critical patent/OA09908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
OA60389A 1991-01-16 1993-07-07 Treatment of neoplastic disease with interleukin-10 OA09908A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64134791A 1991-01-16 1991-01-16

Publications (1)

Publication Number Publication Date
OA09908A true OA09908A (en) 1994-09-15

Family

ID=24571976

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60389A OA09908A (en) 1991-01-16 1993-07-07 Treatment of neoplastic disease with interleukin-10

Country Status (18)

Country Link
EP (1) EP0567576B1 (de)
JP (1) JP3260368B2 (de)
KR (1) KR100207766B1 (de)
AT (1) ATE116550T1 (de)
AU (1) AU652030B2 (de)
CA (1) CA2100553A1 (de)
CZ (1) CZ282523B6 (de)
DE (1) DE69201128T2 (de)
DK (1) DK0567576T3 (de)
ES (1) ES2068705T3 (de)
FI (1) FI933193L (de)
GR (1) GR3015510T3 (de)
HK (1) HK192196A (de)
HU (1) HU218598B (de)
NO (1) NO310444B1 (de)
OA (1) OA09908A (de)
SK (1) SK279556B6 (de)
WO (1) WO1992012725A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
DE4122402A1 (de) * 1991-07-04 1993-01-07 Schering Ag Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
KR0170037B1 (ko) * 1992-08-20 1999-02-01 에릭 에스. 딕커 인터루킨-4 및/또는 인터루킨-10을 함유하는 약제학적 조성물
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
EP0740552A1 (de) * 1994-01-20 1996-11-06 Schering Corporation Verwendung von il-10 zur anregung der zytolischen aktivität von mononucleären zellen in peripherem blut
CA2205572A1 (en) 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
WO2001005821A2 (en) * 1999-07-16 2001-01-25 Maria Teresa Bejarano Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
ES2957546T3 (es) 2008-12-17 2024-01-22 Merck Sharp & Dohme Producción de mono- y di-PEG-IL10; y usos
EP2986306A4 (de) 2013-04-18 2016-12-07 Armo Biosciences Inc Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (de) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15-zusammensetzungen und verwendungen davon
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CA2995120A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
MX9203409A (es) * 1989-12-20 1992-07-01 Schering Corp Proteinas bcrfi como inhibidores de la gama interferona.

Also Published As

Publication number Publication date
FI933193A7 (fi) 1993-07-14
SK279556B6 (sk) 1998-12-02
HU9302066D0 (en) 1993-11-29
ES2068705T3 (es) 1995-04-16
CZ141293A3 (en) 1994-01-19
DE69201128T2 (de) 1995-05-24
GR3015510T3 (en) 1995-06-30
NO932570L (no) 1993-07-15
HU218598B (hu) 2000-10-28
NO310444B1 (no) 2001-07-09
CZ282523B6 (cs) 1997-07-16
HUT69962A (en) 1995-09-28
FI933193A0 (fi) 1993-07-14
CA2100553A1 (en) 1992-07-17
AU1261792A (en) 1992-08-27
EP0567576A1 (de) 1993-11-03
SK74793A3 (en) 1995-03-08
EP0567576B1 (de) 1995-01-04
DK0567576T3 (da) 1995-06-12
NO932570D0 (no) 1993-07-15
ATE116550T1 (de) 1995-01-15
DE69201128D1 (de) 1995-02-16
JPH06504785A (ja) 1994-06-02
HK192196A (en) 1996-10-25
JP3260368B2 (ja) 2002-02-25
KR100207766B1 (ko) 1999-07-15
FI933193L (fi) 1993-07-14
WO1992012725A1 (en) 1992-08-06
AU652030B2 (en) 1994-08-11

Similar Documents

Publication Publication Date Title
GR3015510T3 (en) Treatment of neoplastic disease with interleukin-10.
EG19304A (en) Method of treating pre-menstrual syndrome
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
ZA913282B (en) Dosage form
AU1808488A (en) Compounds for the treatment of alzheimer's disease
EP0102534A3 (en) Hair-growing agent
IE900250L (en) Immunogenic compositions against gastrin peptides
GR3029670T3 (en) Treatment of macular degeneration.
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
SG45366A1 (en) Method of treating and/or diagonising soft tissue tumors
ZA886459B (en) Use of bezafibrate for treating diabetes
MY104521A (en) Treatment of depression.
PH31582A (en) Glycoslated cytokins.
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
PL277464A1 (en) Apparatus for surgical treatment of ametropia
HU900381D0 (en) Process for producing medical preparatives utilizable for treating cancerous diseases
ES2005926A6 (es) Aparato de estimulacion de la piel mediante una senal electromagnetica.
HUT64478A (en) Process for producing medical preparatives for treatment of b-cell tumours
PL283664A1 (en) Therapeutical set for treating limb bone fractures by traction
IL68896A0 (en) Medicine for treatment of neoplastic diseases
IT1243947B (it) 2-azido-ornitina, sua preparazione e suo impiego in terapia
RU93046326A (ru) Способ лечения медикаментозных эзофаго-гингиво-стоматитов
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.